Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Analysts Downgrade to $11

<< Previous

Bullboard Posts

Next >>

Comment by PLITheOneon May 06, 2021 12:53pm

41 Views

Post# 33141520

RE:RE:Analysts Downgrade to $11

Lastest downgraded price estimate on Nasdaq!
Continiously down!

PLITheOne wrote: Straight from Nasdaq, ever heard of them Stickyscamo? Downgrade to $11 although not relevant to current finacials and damaging lawsuit now faced with factored in stil a pipe dream at best. Once Liminial has suckered more in at these inflated prices expect a decline to around $3!

PLITheOne wrote: Check out Nasdaq where Liminal is traded. Now $11, soon to be less. Do fall into the manipulation at hand! They want to steal your money!

Nasdaq Analysts